Home

News

5* JUVE Patent Ranking6 January 2023In the recently published JUVE Patent rankings, 8 New Square was the only UK set to be given a 5* rating.  It received commendation for its FRAND work, commitment to diversity initiatives and its visibility across the field of IP. Please click here for the full analysis.
Philip Morris v Nicoventures Trading [2022] EWCA Civ 163816 December 2022Andrew Lykiardopoulos KC and Adrian Speck KC appeared for the Appellant “PMI” and Respondents “BAT”, respectively,  in the appeal of the order of Marcus Smith J who had held that four patents of PMI for a “heat, not burn” smoking system were invalid for obviousness. The appeal concerned the interpretation of a claim on which the […]
Combe International v Dr August Wolff [2022] EWCA Civ 156230 November 2022Tom Moody-Stuart KC, instructed for the first time on appeal, and Ashton Chantrielle, appeared for Dr Wolff in the appeal of a trade mark infringement and passing off case relating to female intimate care products, in which the Court of Appeal reshaped the law on the statutory acquiescence defence under s48(1) of the Trade Marks […]
Orderly Mind v Queue-It [2022] EWHC 3016 (Ch)22 November 2022Henry Ward successfully represented the Defendant “Queue-It” in a further security for costs application under CPR rule 25.13(2)(c) against the Claimant. The parties had settled the first security for costs application. Bacon J held that the settlement was not a basis for refusing to award further security because the settlement order had envisaged that the […]
8 New Square wins IT/IP Set of the Year at the Chambers and Partners UK Bar Awards 202218 November 20228 New Square is delighted to have won IT/IP Set of the Year at the Chambers and Partners UK Bar Awards 2022.  The awards, which took place at Old Billingsgate on 17th November, recognise Chambers’ pre-eminence in the UK and abroad.  They also reflect achievements over the past 12 months including outstanding work, impressive strategic growth and […]
Teva v Novartis [2022] EWHC 2847 (Pat)10 November 2022Tom Moody-Stuart KC and Henry Ward represented the Claimants, Teva, and the Defendants, Novartis, respectively, in an action for revocation of two Novartis patents for a swallowable tablet containing deferasirox – a compound used in the treatment of iron overload – and a declaration of non-infringement for Teva’s product Teva DFX. Novartis counterclaimed for infringement. […]
Nokia v Oppo [2022] EWHC 2814 (Pat)9 November 2022Michael Tappin KC successfully represented Nokia in a patent infringement action against the Defendants “Oppo” who counterclaimed for invalidity. The patent in issue, which was not essential, was for a mobile phone transmitter. Nokia sought to prove infringement by doing experiments and by obtaining disclosure from a third party in the US courts using the […]
Kigen v Thales [2022] EWHC 2846 (Pat)8 November 2022Mark Chacksfield KC and Thomas Jones represented the patentee, Thales, in its jurisdictional or case management challenge seeking to stay a claim for a FRAND determination brought by Kigen, the implementer of standardised eSIM technology. Fancourt J held that while the Court had jurisdiction to determine the FRAND terms notwithstanding that Kigen refused to give […]
Optis v Apple [2022] EWCA Civ 141127 October 2022Isabel Jamal and Jennifer Dixon appeared for the Claimants (“Optis”), in the appeal of the judgment of Meade J in “Trial F” in proceedings against the Defendants (“Apple”). Meade J had decided that the owner of a patent is entitled to an immediate “FRAND injunction” once the court has found the patent to be valid, […]
Pasternak v Prescott [2022] EWHC 2695 (Ch)25 October 2022Andrew Lykiardopoulos KC and Henry Edwards successfully represented the Defendant Lara Prescott in Pasternak v Prescott, the recent litigation concerning Doctor Zhivago. The Claimant was the journalist Anna Pasternak, the great-niece of Boris Pasternak. Ms Pasternak wrote Lara: The Untold Love Story and the Inspiration for Doctor Zhivago, published in 2016. Lara is a non-fiction […]